Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Express Scripts/Medco Merger's Impact On Small Pharmacies Is Focus Of Hearing

This article was originally published in The Pink Sheet Daily

Executive Summary

Express Scripts CEO tells House Judiciary subcommittee that the companies would not be in favor of divesting their mail order and specialty pharmaceutical businesses.
Advertisement

Related Content

Specialty Pharmacy Opens The Door – For Continued PBM Antitrust Litigation
Express Scripts/Medco Merger Faces Longer Odds After FTC's Second Request
FTC Review Of Express Scripts/Medco Merger Is First Integration Challenge
FTC Review Of Express Scripts/Medco Merger Is First Integration Challenge

Topics

Advertisement
UsernamePublicRestriction

Register

PS072796

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel